BCAP29
B-cell receptor-associated protein 29
Also known as: BAP29, BAP29_HUMAN, DKFZp686M2086
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UHQ4
- Gene
- BCAP29
- Ensembl
- ENSG00000075790
- Chromosome
- 7
- Canonical length
- 241 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Involved in osteoblast differentiation. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
241 residues, UniProt reviewed canonical sequence.
>Q9UHQ4|BCAP29
1 MTLQWAAVAT FLYAEIGLIL IFCLPFIPPQ RWQKIFSFNV WGKIATFWNK AFLTIIILLI
61 VLFLDAVREV RKYSSVHTIE KSSTSRPDAY EHTQMKLFRS QRNLYISGFS LFFWLVLRRL
121 VTLITQLAKE LSNKGVLKTQ AENTNKAAKK FMEENEKLKR ILKSHGKDEE CVLEAENKKL
181 VEDQEKLKTE LRKTSDALSK AQNDVMEMKM QSERLSKEYD QLLKEHSELQ DRLERGNKKR
241 LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCAP29 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 81 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 81 nTPM
- testis: 66 nTPM
- heart muscle: 58 nTPM
- blood vessel: 49 nTPM
- cervix: 47 nTPM
- adipose tissue: 45 nTPM
Single-cell type
- brain excitatory neurons: 84 nCPM
- renal collecting duct intercalated cells: 84 nCPM
- brain inhibitory neurons: 69 nCPM
- oligodendrocyte progenitor cells: 65 nCPM
- oligodendrocytes: 63 nCPM
- bergmann glia: 61 nCPM
Immune cell
- basophil: 50 nTPM
- eosinophil: 26 nTPM
- non-classical monocyte: 22 nTPM
- intermediate monocyte: 14 nTPM
- T-reg: 14 nTPM
- memory B-cell: 13 nTPM
Brain region
- cerebral cortex: 44 nTPM
- basal ganglia: 42 nTPM
- white matter: 38 nTPM
- spinal cord: 35 nTPM
- thalamus: 34 nTPM
- hypothalamus: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.26
- gnomAD missense Z
- -0.32
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- endoplasmic reticulum to Golgi vesicle-mediated transport
- intracellular protein transport
- osteoblast differentiation
- protein localization to endoplasmic reticulum exit site
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BCAP29 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCAP29 as an antibody target. Whether an autoantibody or antibody against BCAP29 could matter depends on whether native BCAP29 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCAP29 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCAP29 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...